查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2023450

器官晶片平台市场分析与预测（至2035年）：按类型、产品、服务、技术、组件、应用、材料类型、最终用户和功能划分

Organ-on-Chip Platforms Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球器官晶片平台市场预计将从2025年的3亿美元成长到2035年的20亿美元，复合年增长率（CAGR）为32.2%。预计到2026年，器官晶片平台的部署数量将超过15万个。药物研发（R&D）应用占65%。与传统模型相比，药物测试的准确性提高了30-40%。北美占48%的市场份额，部署量正以32%的复合年增长率快速成长。预计到2030年，超过50%的临床前试验将采用器官晶片技术，减少对动物试验的依赖。

器官晶片平台正推动药物研发领域的强劲成长，因为它们提供了一种更精准、更有效率的药物反应测试方法。这些系统能够模拟人体器官功能，使研究人员无需过度依赖动物实验即可评估药物的疗效和毒性。製药公司正在采用这项技术来提高研发成功率，同时缩短研发时间并降低成本。对个人化医疗日益增长的需求也推动了市场成长。随着对先进测试方法的需求不断增加，器官晶片平台正成为製药业的关键创新，并正在改变传统的药物研发流程。

市场区隔
种类 肝臟晶片、心晶片、肺晶片、肾臟晶片、肠道晶片、脑晶片、皮肤晶片等等
产品 耗材、设备、软体及其他
服务 咨询、整合、维护及其他服务。
科技 微流体、3D细胞培养、生物列印及其他
成分 微晶片、微流控、感测器及其他
目的 药物发现、毒性研究、疾病建模、个人化医疗等。
材料类型 聚合物、玻璃、硅、水凝胶及其他
最终用户 製药公司、学术和研究机构、生物技术公司、合约研究组织 (CRO) 及其他
功能 人体生理功能模拟、即时监测、高通量筛检等。

微流体技术因其能够在微观层面精确控制流体流动而迅速发展。这使得微流控技术能够精确模拟生物环境，使其成为器官晶片系统不可或缺的一部分。微加工和设计技术的不断进步正在提升其性能和扩充性。随着研发活动的增加，微流体技术正成为生物医学领域创新中不可或缺的要素。其模拟复杂生理条件的能力正在推动其快速普及，并使其成为支撑器官晶片平台市场成长的关键技术。

区域概览

北美地区凭藉其先进的生物医学研究和强大的製药实力，预计将在2025年引领器官晶片平台市场的发展。在美国，器官晶片模型在药物测试和疾病研究中的日益普及推动了该技术的广泛应用。领先的生物技术公司和研究机构的存在促进了创新。此外，监管机构对替代测试方法的支持正在减少对动物实验的依赖。对个人化医疗日益增长的需求也进一步推动了市场成长。这些因素使得北美成为成长率最高的地区。

预计欧洲将成为成长最快的地区，这主要得益于人们对伦理研究实践和先进医疗技术的日益重视。德国和英国等国正在投资器官晶片研究。精准药物测试模型的需求不断增长，推动了相关技术的应用。此外，政府资助以及学术机构与製药公司之间的合作也为成长提供了支持。随着减少动物实验的呼声日益高涨，欧洲的扩张速度进一步加快，使其成为全球成长最快的地区。

主要趋势和驱动因素

加速向非动物药物测试模式的转变：

由于药物测试方法朝向符合伦理且不涉及动物的模式转变，器官晶片平台市场正在蓬勃发展。製药和生物技术公司正采用器官晶片系统来模拟人体器官功能，其精确度远超传统的动物模型。这些微型工程装置能够复製生理反应，从而提高药物疗效和毒性预测的准确性。监管机构也在推荐动物试验的替代方案。随着药物研发对精准度的要求越来越高，器官晶片技术在减少试验失败和加速临床研究方面的重要性日益凸显，推动了全球市场的强劲成长。

微流体和组织工程技术的进展：

微流体和组织工程领域的技术进步是推动器官晶片平台市场发展的主要动力。晶片製造技术的创新使得对流体流动和细胞环境的精确控製成为可能，从而实现逼真的器官级模拟。干细胞技术的整合提高了生物学精确性和扩充性。研究人员也正在开发多器官晶片系统，模拟复杂的人体相互作用。这些进步提高了药物测试的可靠性并降低了研发成本。随着生物医学工程的不断发展，器官晶片平台有望成为药物研发和个人化医疗中不可或缺的工具。

目录

第一章执行摘要

第二章 市场概览

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 肝片
    • 心形晶片
    • 肺晶片
    • 肾形片
    • 肠片
    • 脑晶片
    • 皮肤碎片
    • 其他的
  • 市场规模及预测：依产品划分
    • 消耗品
    • 装置
    • 软体
    • 其他的
  • 市场规模及预测：依服务划分
    • 咨询
    • 一体化
    • 维护
    • 其他的
  • 市场规模及预测：依技术划分
    • 微流体
    • 3D细胞培养
    • 生物列印
    • 其他的
  • 市场规模及预测：依组件划分
    • 微晶片
    • 微流控
    • 感应器
    • 其他的
  • 市场规模及预测：依应用领域划分
    • 药物发现
    • 毒性研究
    • 疾病建模
    • 个人化医疗
    • 其他的
  • 市场规模及预测：依材料类型划分
    • 聚合物
    • 玻璃
    • 硅
    • 水凝胶
    • 其他的
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 学术和研究机构
    • 生技公司
    • CRO（委外研发机构）
    • 其他的
  • 市场规模及预测：依功能划分
    • 人体生理功能模拟
    • 即时监控
    • 高通量筛检
    • 其他的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Emulate
  • CN Bio Innovations
  • TissUse
  • Mimetas
  • Hesperos
  • Tara Biosystems
  • InSphero
  • Kirkstall
  • Nortis
  • AxoSim
  • BiomimX
  • Hurel Corporation
  • Cherry Biotech
  • AlveoliX
  • Elveflow
  • Micronit
  • SynVivo
  • Organovo
  • Draper
  • Altis Biosystems

第九章：关于环球透视服务公司

简介目录
Product Code: GIS34486

The global organ-on-chip platforms market is projected to grow from $0.3 billion in 2025 to $2.0 billion by 2035, at a compound annual growth rate (CAGR) of 32.2%. Organ-on-chip platforms are expected to exceed 150,000 units in deployment by 2026. Pharmaceutical R&D accounts for 65% of usage. Drug testing accuracy improves by 30-40% compared to traditional models. North America holds 48% share. Adoption is growing at 32% CAGR. By 2030, over 50% of preclinical testing is expected to incorporate organ-on-chip technologies, reducing reliance on animal testing.

Drug discovery is driving strong growth as organ-on-chip platforms provide more accurate and efficient methods for testing drug responses. These systems simulate human organ functions, allowing researchers to evaluate drug efficacy and toxicity without relying heavily on animal testing. Pharmaceutical companies are adopting this technology to reduce development time and costs while improving success rates. Increasing demand for personalized medicine is also supporting growth. As the need for advanced testing methods continues to rise, organ-on-chip platforms are becoming a key innovation in the pharmaceutical industry, transforming traditional drug development processes.

Market Segmentation
TypeLiver-on-Chip, Heart-on-Chip, Lung-on-Chip, Kidney-on-Chip, Intestine-on-Chip, Brain-on-Chip, Skin-on-Chip, Others
ProductConsumables, Instruments, Software, Others
ServicesConsulting, Integration, Maintenance, Others
TechnologyMicrofluidics, 3D Cell Culture, Bioprinting, Others
ComponentMicrochips, Microfluidic Channels, Sensors, Others
ApplicationDrug Discovery, Toxicology Research, Disease Modeling, Personalized Medicine, Others
Material TypePolymers, Glass, Silicon, Hydrogels, Others
End UserPharmaceutical Companies, Academic Research Institutes, Biotechnology Companies, Contract Research Organizations, Others
FunctionalityMimicking Human Physiology, Real-time Monitoring, High-throughput Screening, Others

Microfluidics technology is expanding rapidly due to its ability to precisely control fluid flow at a microscopic level. This enables accurate simulation of biological environments, making it essential for organ-on-chip systems. Continuous advancements in microfabrication and design are improving performance and scalability. As research and development activities increase, microfluidics is becoming a critical component in biomedical innovation. Its ability to replicate complex physiological conditions is driving rapid adoption, making it a key technology supporting the growth of the organ-on-chip platforms market.

Geographical Overview

North America leads the organ-on-chip platforms market in 2025 due to advanced biomedical research and strong pharmaceutical industry presence. The United States drives adoption with increasing use of organ-on-chip models for drug testing and disease research. The presence of leading biotech firms and research institutions enhances innovation. Additionally, regulatory support for alternative testing methods reduces reliance on animal testing. Growing demand for personalized medicine further boosts growth. These factors position North America as the highest growing regional market.

Europe is projected to be the fastest growing region due to increasing focus on ethical research practices and advanced healthcare technologies. Countries like Germany and the UK are investing in organ-on-chip research. Rising demand for accurate drug testing models drives adoption. Additionally, government funding and collaboration between academic institutions and pharmaceutical companies support growth. Increasing emphasis on reducing animal testing further accelerates expansion, making Europe the fastest growing region globally.

Key Trends and Drivers

Rising Shift Toward Animal-Free Drug Testing Models:

The Organ-on-Chip Platforms Market is growing due to the increasing shift toward ethical, animal-free drug testing methods. Pharmaceutical and biotechnology companies are adopting organ-on-chip systems to simulate human organ functions more accurately than traditional animal models. These microengineered devices replicate physiological responses, enabling better prediction of drug efficacy and toxicity. Regulatory agencies are also encouraging alternatives to animal testing. As drug development becomes more precision-driven, organ-on-chip technology is gaining importance for reducing trial failures and accelerating clinical research processes, thereby driving strong market growth globally.

Advancements in Microfluidics and Tissue Engineering Technologies:

Technological advancements in microfluidics and tissue engineering are key drivers of the Organ-on-Chip Platforms Market. Innovations in chip fabrication allow precise control of fluid flow and cellular environments, enabling realistic organ-level simulations. Integration of stem cell technology is improving biological accuracy and scalability. Researchers are also developing multi-organ chip systems to replicate complex human interactions. These advancements are enhancing drug testing reliability and reducing development costs. As biomedical engineering progresses, organ-on-chip platforms are expected to become essential tools in pharmaceutical research and personalized medicine.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Strategic Recommendations
  • 1.5 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Technologies Landscape
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Liver-on-Chip
    • 4.1.2 Heart-on-Chip
    • 4.1.3 Lung-on-Chip
    • 4.1.4 Kidney-on-Chip
    • 4.1.5 Intestine-on-Chip
    • 4.1.6 Brain-on-Chip
    • 4.1.7 Skin-on-Chip
    • 4.1.8 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Consumables
    • 4.2.2 Instruments
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Integration
    • 4.3.3 Maintenance
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Microfluidics
    • 4.4.2 3D Cell Culture
    • 4.4.3 Bioprinting
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Microchips
    • 4.5.2 Microfluidic Channels
    • 4.5.3 Sensors
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Drug Discovery
    • 4.6.2 Toxicology Research
    • 4.6.3 Disease Modeling
    • 4.6.4 Personalized Medicine
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Polymers
    • 4.7.2 Glass
    • 4.7.3 Silicon
    • 4.7.4 Hydrogels
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Pharmaceutical Companies
    • 4.8.2 Academic Research Institutes
    • 4.8.3 Biotechnology Companies
    • 4.8.4 CROs
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Mimicking Human Physiology
    • 4.9.2 Real-time Monitoring
    • 4.9.3 High-throughput Screening
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Material Type
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Material Type
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Material Type
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Material Type
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Material Type
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Material Type
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Material Type
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Material Type
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Material Type
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Material Type
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Material Type
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
    • 5.4.6 Rest of APAC
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Material Type
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Material Type
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Material Type
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Material Type
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
    • 5.5.4 Italy
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Material Type
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
    • 5.5.5 Rest of Europe
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Material Type
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Material Type
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Material Type
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.5.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Material Type
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
    • 5.6.4 Rest of MEA
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Material Type
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Emulate
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 CN Bio Innovations
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 TissUse
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Mimetas
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Hesperos
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Tara Biosystems
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 InSphero
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Kirkstall
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Nortis
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 AxoSim
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 BiomimX
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Hurel Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Cherry Biotech
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 AlveoliX
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Elveflow
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Micronit
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 SynVivo
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Organovo
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Draper
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Altis Biosystems
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us